[New therapeutic contribution in dyspneic respiratory diseases].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000188:drug therapy*; D004417:Dyspnea / Q000188:drug therapy*; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D013141:Spiro Compounds / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D013141:Spiro Compounds
Apport thérapeutique nouveau dans les affections respiratoires dyspnéisantes.